KIFC3 and colorectal carcinoma: Therefore, we will knock down KIFC3 by CRISPR/Cas9 or siRNA, or overexpress KIFC3 by plasmid, and observe its effects on CRC cell proliferation, migration, invasion, immune cell function or related pathway interactions.